Evidence map›Paper›PMID 32157172›Full record

ArticleCommunications biology2020

Spatial and temporal tracking of cardiac exosomes in mouse using a nano-luciferase-CD63 fusion protein.

Weijia Luo, Yuan Dai, Zhishi Chen, Xiaojing Yue, Kelsey C Andrade-Powell, Jiang Chang

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Weijia LuoCenter for Genomic and Precision Medicine, Texas A&M University, Institute of Biosciences and Technology, Houston, TX, 77030, USA.
Yuan DaiCenter for Genomic and Precision Medicine, Texas A&M University, Institute of Biosciences and Technology, Houston, TX, 77030, USA.
Zhishi ChenCenter for Genomic and Precision Medicine, Texas A&M University, Institute of Biosciences and Technology, Houston, TX, 77030, USA.
Xiaojing YueDepartment of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China.
Kelsey C Andrade-PowellCenter for Genomic and Precision Medicine, Texas A&M University, Institute of Biosciences and Technology, Houston, TX, 77030, USA.
Jiang ChangCenter for Genomic and Precision Medicine, Texas A&M University, Institute of Biosciences and Technology, Houston, TX, 77030, USA. jiangchang@tamu.edu.
Texas A&M University · USSouthern Medical University · CN

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Exosomes are secreted extracellular vesicles with lipid bilayer membranes. They are emerging as a new category of messengers that facilitate cross-talk between cells, tissues, and organs. Thus, a critical demand arises for the development of a sensitive and non-invasive tracking system for endogenous exosomes. We have generated a genetic mouse model that meets this goal. The Nano-luciferase (NanoLuc) reporter was fused with the exosome surface marker CD63 for exosome labeling. The cardiomyocyte-specific αMHC promoter followed by the loxP-STOP-loxP cassette was engineered for temporal and spatial labeling of exosomes originated from cardiomyocytes. The transgenic mouse was bred with a tamoxifen-inducible Cre mouse (Rosa26Cre-ERT2) to achieve inducible expression of CD63NanoLuc reporter. The specific labeling and tissue distribution of endogenous exosomes released from cardiomyocytes were demonstrated by luciferase assay and non-invasive bioluminescent live imaging. This endogenous exosome tracking mouse provides a useful tool for a range of research applications.

Indexed as

AnimalsAnimals, Genetically ModifiedCells, CulturedExosomesFibroblastsIntegrasesLuciferasesLuminescent MeasurementsMaleMice, Inbred C57BLMyocytes, CardiacMyosin Heavy ChainsPromoter Regions, GeneticRecombinant Fusion ProteinsRNA, UntranslatedTetraspanin 30Cre recombinaseGt(ROSA)26Sor non-coding RNA, mouseIntegrasesLuciferasesMyh6 protein, mouseMyosin Heavy ChainsRecombinant Fusion ProteinsRNA, UntranslatedTetraspanin 30

Identifiers

PMID32157172
PMCPMC7064570
OpenAlexW3011668109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.